Learning Objectives

• Discuss the evaluation involved in diagnosing AD or MCI due to AD, including the expanding role of biomarkers to aid early and accurate diagnosis
• Examine the roles of PCPs and dementia specialists in the diagnosis and management of AD
• Explore the evidence supporting new and emerging anti-amyloid therapies
• Consider which patients are most likely to benefit from these therapies